logo_db.gif (1248 bytes)

Flash! Archive
June 2002

May 2002

April 2002

March 2002

February 2002

January 2002

December 2001

November 2001
October 2001
September 2001
August 2001
July 2001
June 2001
May 2001
April 2001
March 2001
February 2001
January 2001
December 2000
November 2000
October 2000
September 2000
August 2000
July 2000
June 2000
May 2000

ESA Sponsors Bioreactor Research On ISS


The European Space Agency (ESA) and researchers from academia and industry in Germany, Italy and Switzerland will sign a contract for a health research project which will lay the scientific and industrial foundations for the development of a space bioreactor for biomedical applications to be set up on the International Space Station.

A bioreactor is a cultivation vessel used in research laboratories and industrial production to grow bacteria, yeast or animal cells and, increasingly in the recent past, tissues. The one to be developed under this contract will be designed specifically for mammalian cell cultivation and will be used on the International Space Station to study the cultivation of medically relevant cells, tissues and organ-like structures, with particular emphasis on vessels and cartilage.

Growing tissue samples in vitro, i.e. in a bioreactor, is currently one of the major goals of medical research. The principles of in vitro cell culture have been known for almost 100 years, but only in the last 10 - 20 years has the cultivation of mammalian cultures increased significantly, leading to the creation of the discipline of tissue engineering. Space research has potential to give a boost to tissue engineering. As compared to the normal gravity conditions on Earth, a weightlessness environment may provide much better conditions for obtaining proper three-dimensional cell structures.

The modular space bioreactor for growing medically relevant organ-like structures proposed by a European scientific and industrial research team under the coordination of Prof. Augusto Cogoli from the Swiss Federal Technical University in Zurich will play an essential part in clarifying cellular and molecular mechanisms responsible for cell aggregation and differentiation control mechanisms and also in obtaining better pseudo-organs for possible clinical uses. Prof. Cogoli's team comprises members from Switzerland, Italy and Germany: Dr Isabelle Walther from the Swiss Federal Technical University, Zurich, Dr Werner Muller from the Sulzer Medica company in Winterthur, Prof. Saverio Ambesi-Impiombato from the University of Udine, Dr Augustinus Bader from the Medical University of Hannover, Prof. Peter Bruckner from the University of Munster and Dr Ralf Pörtner from the Technical University of Hamburg-Harburg. 


Copyright 2001 - Andrews Space & Technology
Andrews Space & Technology Privacy Statement and Copyright Information

SPACEandTECH Digest is a weekly roundup of the latest industry news of interest to the space professional. SPACEandTECH Flash! is an internet push service offered by Andrews Space & Technology to bring the latest on orders, launches, and important breaking news to your desktop. SPACEandTECH Digest and SPACEandTECH Flash! are part of the Andrews Space & Technology www.spaceandtech.com website, a website designed to serve the information needs of the space industry.

If you would like to subscribe to the SPACEandTECH Flash! (currently a free service), contact the www.spaceandtech.com Editor-in-Chief, Joe Hopkins, at editor@spaceandtech.com



May 1, 2000

space.gif (43 bytes)


On the Pads provides a summary of upcoming launches.

Advertise with SPACEandTECH

Advertise with SPACEandTECH

Advertise with SPACEandTECH